MIF and head and neck squamous cell carcinoma: Increased MIF expression has been observed in head and neck squamous cell carcinomas (HNSCC), specifically in the nasopharygeal carcinoma (NPC) (127), hypopharynx carcinoma (132), laryngopharyngeal carcinoma (253), and oral squamous cell carcinoma (OSCC) (129).